Cytosorbents
CTSO
#9834
Rank
NZ$78.51 M
Marketcap
NZ$1.25
Share price
-0.89%
Change (1 day)
-17.06%
Change (1 year)

Market capitalization of Cytosorbents (CTSO)

Market cap: NZ$78.51 Million

As of December 2025 Cytosorbents has a market cap of NZ$78.51 Million. This makes Cytosorbents the world's 9834th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytosorbents from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$78.51 M-14.27%
2024NZ$91.58 M0.01%
2023NZ$91.57 M-14.04%
2022NZ$0.10 B-60.06%
2021NZ$0.26 B-44.14%
2020NZ$0.47 B156.06%
2019NZ$0.18 B-51.29%
2018NZ$0.38 B45.76%
2017NZ$0.26 B31.04%
2016NZ$0.20 B-3.05%
2015NZ$0.20 B-30.16%
2014NZ$0.29 B674.15%
2013NZ$38.22 M12.53%
2012NZ$33.97 M-6.59%
2011NZ$36.36 M63.15%
2010NZ$22.29 M28.38%
2009NZ$17.36 M398.55%
2008NZ$3.48 M

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Cytosorbents was reported to be:

NZ$78.51 Million
by Nasdaq info icon info icon
NZ$78.51 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Meridian Bioscience
VIVO
NZ$2.57 B 3,176.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$28.82 B 36,613.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$240.33 B 306,010.16%๐Ÿ‡บ๐Ÿ‡ธ USA